Although the enhanced antigen-presenting capabilities and proinflammatory characteristics of memory B cells from MS patients have been well-established, these new findings provide further evidence supporting the likelihood that T-bet+ memory B cells reactivate encephalitogenic CD4+ T cells in the brain. Here, CD4 is linked to myeloid sarcoma.